Skip to main content

REVIEW article

Front. Pharmacol.

Sec. Pharmacology of Anti-Cancer Drugs

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1579609

This article is part of the Research Topic Phytochemical Interventions to Cancer View all articles

Recent advancement in the anticancer efficacy of the natural flavonoid Scutellarin: A comprehensive review

Provisionally accepted
Deena Elsori Deena Elsori 1Pratibha Pandey Pratibha Pandey 2Meenakshi Verma Meenakshi Verma 3Nasir Vadia Nasir Vadia 4Roopashree R Roopashree R 5Manish Vyas Manish Vyas 6L Lakshmi L Lakshmi 7Laxmidhar Maharana Laxmidhar Maharana 8Deepak Nathiya Deepak Nathiya 9Mohd Saeed Mohd Saeed 10Safia Obaidur Safia Obaidur 11*Dr. Fahad Khan Dr. Fahad Khan 12*
  • 1 Rabdan Academy, Abu Dhabi, United Arab Emirates
  • 2 Centre for Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, India
  • 3 Chandigarh University, Mohali, Punjab, India
  • 4 Marwadi University, Rajkot, Gujarat, India
  • 5 Jain University, Bengaluru, Karnataka, India
  • 6 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • 7 Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India
  • 8 Siksha O Anusandhan University, Bhubaneswar, Odisha, India
  • 9 NIMS University, Jaipur, Rajasthan, India
  • 10 University of Hail, Ha'il, Hail, Saudi Arabia
  • 11 King Khalid University, Abha, Saudi Arabia
  • 12 Saveetha Medical College & Hospital, Chennai, India

The final, formatted version of the article will be published soon.

    Scutellarin (SC), a natural flavonoid, has been expansively employed in treating innumerable inflammation-related diseases due to its antitumor, antiinflammatory, anticancer, and antioxidant potential. Scutellarin can inhibit significant inflammatory cell signaling pathways, comprisingPI3K/Akt, NF-κB, and MAPK, and while activating antioxidant-related pathways such as Nrf2 and ARE. Numerous reviews have outlined scutellarin's pharmacological effects and associated mechanisms in inflammation-related diseases. Several studies have elucidated the mechanisms of anticancer activity by inhibiting various signaling pathways; however, to our knowledge, none of the reviews have distinguished the anticancer potential of scutellarin based on different human cancer types. Our review outlined detailed insights about the anticancer potential of scutellarin based on cancer type in the human body. Furthermore, we have also outlined formulations, combinatorial therapies, and comprehensive mechanistic research to deliver enhanced and effective treatment options for cancer patients. This study will provide thorough and detailed insights into scutellarin, supporting its development as a promising candidate for cancer treatment.

    Keywords: Scutellarin, Natural flavonoids, Cancer, formulations, Signaling Pathways

    Received: 19 Feb 2025; Accepted: 12 Mar 2025.

    Copyright: © 2025 Elsori, Pandey, Verma, Vadia, R, Vyas, Lakshmi, Maharana, Nathiya, Saeed, Obaidur and Khan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Safia Obaidur, King Khalid University, Abha, 61431, Saudi Arabia
    Dr. Fahad Khan, Saveetha Medical College & Hospital, Chennai, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    People also looked at

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more